Marker Therapeutics Inc. Watch

EX-10.2

from 8-K 29 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 48 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 48 pages Securities Purchase Agreement

12/34/56

EX-10.9

from 10-K 12 pages Work Order #1 Gmp-Q1-2024 Marker Gmp Manufacturing Proposal on February 22nd, 2024

12/34/56

EX-10.8

from 10-K 27 pages Master Services Agreement for Product Supply

12/34/56

EX-10.2

from 10-Q 17 pages ​ Agreement ​

12/34/56

EX-10.1

from 10-Q 8 pages ​ April 27, 2023 ​ Peter L. Hoang 3787 Bissonnet St Houston , Tx 77005 ​ Dear Peter: ​ This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Marker Therapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition. ​

12/34/56

EX-10.2

from 8-K 17 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 36 pages Purchase Agreement

12/34/56

EX-10.2

from 10-Q 32 pages ​ Marker Therapeutics, Inc. 2020 Equity Incentive Plan

12/34/56

EX-10.1

from 10-Q 8 pages ​ Marker Therapeutics, Inc. Rsu Award Grant Notice

12/34/56

EX-10.1

from 8-K 4 pages Binding Services Agreement (The “Agreement”) Between Wilson Wolf Manufacturing Corporation (“Wilson Wolf”) and Marker Therapeutics, Inc. (“Marker”) Dated April 21, 2022

12/34/56

EX-10.2

from 10-Q 7 pages Marker Therapeutics, Inc. Rsu Award Grant Notice

12/34/56

EX-10.1

from 10-Q 9 pages Marker Therapeutics, Inc. Stock Option Grant Notice

12/34/56

EX-10.1

from 8-K 32 pages Common Stock Purchase Agreement

12/34/56

EX-10.3

from 10-Q 18 pages Marker Therapeutics, Inc. Employment Agreement

12/34/56

EX-10.40

from 10-K 4 pages Amendment to Employment Agreement

12/34/56

EX-10.39

from 10-K 14 pages Indemnification Agreement

12/34/56

EX-10.38

from 10-K 11 pages Marker Therapeutics, Inc. Consulting Services Agreement

12/34/56

EX-10.22

from 10-K 16 pages Sponsored Research Contract

12/34/56